fda compounding semaglutide enforcement october 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compound versions of GLP-1 drugs

It gathers information about your medical history, current medications, weight management goals, and other health factors

Resistance exercises and daily movement boost metabolism

23 The assessment of major birth defects was restricted to live births and pregnancy losses with confirmed outcomes after appropriate medical examination, ensuring reliable knowledge of birth defect status

We provide a discreet and personalized approach, ensuring your treatment plan-whether it includes Wegovy, Zepbound, or a combination of support-is perfectly matched to your individual health needs and goals

[DOI] [PMC free article] [PubMed] [Google Scholar] 151.Goodwin P.J., Chen B.E., Gelmon K.A., Whelan T.J., Ennis M., Lemieux J., Ligibel J.A., Hershman D.L., Mayer I.A., Hobday T.J., et al

doi:10.1056/nejmoa2511774 8.Jastreboff AM, Kaplan LM, Fras JP, et al